NOVO NORDISK PHARMACEUTICALS A/S

NOVO NORDISK PHARMACEUTICALS A/S (CVR number: 24257924) is a company from GLADSAXE. The company recorded a gross profit of -46 kDKK in 2023. The operating profit was -5904 kDKK, while net earnings were -2258 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0.8 %, which can be considered poor and Return on Equity (ROE) was -2.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 93 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. NOVO NORDISK PHARMACEUTICALS A/S's liquidity measured by quick ratio was 13.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.